However, the bioavailability of oral glutathione is relatively low, as a significant portion may be broken down in the digestive tract before it can be absorbed into the bloodstream
[] Furthermore, because of DFOs principal limitation as a therapeutic agent being limited by its mode of administration, which is primarily parenteral and the associated issues related to its administration, much research is still needed to develop DFO derivatives with greater therapeutic potentialities
A mutation associated with Arts Syndrome, PRPS1 R196W, exhibits decreased O -GlcNAcylation levels and activity of PRPS1
The lower dose of 500 mg daily led to the most pronounced rise in glutathione levels
Systemically, F.n regulates intestinal butyrate metabolism through the AMPK pathway, thereby impacting the initiation, progression, and prognosis of colorectal cancer (CRC) (Wu et al., 2024)